Novartis was seeking a way to educate the public about their advancements in flu vaccine technology. They developed Flucelvax, the first anti-biotic free, cell culture vaccine of its kind. I helped envision Flucelvax’s web presence, and created a parallax home page experience that quickly tells the story of the brand. The story is punctuated by the world’s first socially enabled flu tracker, which gathers Twitter data and parses it to predict localized flu outbreaks. I also designed the site’s interactive timeline that leads the users through the history of influenza and the flu vaccine.